Category: compounding

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019  — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →

Read more

Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address

  In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof…. Continue Reading →

Read more
Menopause specialists warn against dangers of “bioidentical hormones” thumbnail
Categories: ,

Menopause specialists warn against dangers of “bioidentical hormones”

On Monday 15th July 2019 in a comprehensive interview on the Life Matters program (ABC Radio National) two of Australia’s premier menopause specialists, Dr Elizabeth Farrell and… Continue Reading →

Read more
Federal Court Proceedings Demonstrate Risk  To Compounding Pharmacies thumbnail
Categories: ,

Federal Court Proceedings Demonstrate Risk To Compounding Pharmacies

MEDIA RELEASE 3rd August 2017   A recent Federal Court case highlights the very real risk and cost to Compounding Pharmacies who do not… Continue Reading →

Read more